Varex Imaging Corporation (VREX) stock analysis
Healthcare · Medical Devices
From the 10-K filed 2025-11-18
How it makes money
It earns by selling X-ray components to medical and industrial OEMs, with profit driven by the high-frequency replacement cycle of specialized tubes.
It acts as a primary component supplier, embedding its hardware and software into OEM systems. Because these systems require regulatory approval to change, customers face significant switching costs.
Profitability relies heavily on its installed base of over 160,000 tubes. Since components like CT tubes wear out and require replacement every 2 to 20 months depending on usage, the recurring demand for service and replacement parts creates a persistent revenue stream distinct from new system sales.
What protects it: the moat
It relies on tight technical integration and regulatory registration requirements to prevent OEMs from switching to competing suppliers.
Management asserts that its competitive advantage stems from the deep customization of its components to specific customer equipment. By becoming part of the regulatory approval process for these medical systems, it creates a barrier where switching providers would force customers to restart costly compliance and validation procedures.
What growth costs
It sustains its position through ongoing R&D investment and manufacturing scale, though it provides no specific annual capital expenditure targets.
It maintains a specialized workforce of approximately 400 individuals focused on product development. The company leverages its scale as a large independent supplier to optimize costs, but it does not disclose specific figures for maintenance versus growth-related capital outlays.
What could damage it
Chinese government policies favoring domestic suppliers threaten its market access, potentially severing its revenue connection to a critical geographic segment.
As China prioritizes reducing reliance on foreign technology, the government may compel its local manufacturers to source components from domestic alternatives. Since 10% of total revenue is derived from exporting medical X-ray tubes into this region, any policy shift mandating local sourcing or providing subsidies to domestic competitors would directly erode its installed base and replacement revenue in that market.
About Varex Imaging Corporation
Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. It operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers. This segment's products are used in a range of applications, including CT, mammography, oncology, cardiac, surgery, dental, and other diagnostic radiography uses. The Industrial segment designs, develops, manufactures, sells, and services Linatron X-ray linear accelerators, non-intrusive cargo inspection systems, X-ray tubes, digital detectors, high voltage connectors, and coolers for use in security and inspection applications, such as baggage screening at airports, cargo screening at ports and borders, and nondestructive testing, irradiation, and inspection in various applications. It sells its products through imaging system original equipment manufacturers, independent service companies, and distributors, as well as directly to end-users. The company has operations in North America, Latin America, Europe, the Middle East, India, Africa, Asia, and Australia. The company was incorporated in 2016 and is headquartered in Salt Lake City, Utah.